(Q43152545)

English

Cyclooxygenase-2 inhibition does not improve the reduction in ductal carcinoma in situ proliferation with aromatase inhibitor therapy: results of the ERISAC randomized placebo-controlled trial

scientific article published on 23 February 2010

Statements

Cyclooxygenase-2 inhibition does not improve the reduction in ductal carcinoma in situ proliferation with aromatase inhibitor therapy: results of the ERISAC randomized placebo-controlled trial (English)
0 references
Nigel J Bundred
Angela Cramer
Julie Morris
Lorna Renshaw
Kwok-Leung Cheung
Pamela Flint
Rachael Johnson
Oliver Young
Göran Landberg
Sue Grassby
Lorraine Turner
Andrew Baildam
J Michael Dixon
23 February 2010
1605-1612

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit